Related Experiment Video
Updated: Aug 5, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Impact of Zip-Based Social Determinants on Textbook Outcomes and Survival of Resected Early-Stage NSCLC
Ahmed Alnajar1, Benjamin Nguyen1, Nestor Villamizar1
1Division of Cardiothoracic Surgery, The DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL.
Background:
This study investigates the impact of ZIP-code-based social determinants of health (SDH) on textbook oncological outcomes (TOO) and overall survival (OS) in patients with surgically resected clinical stage IA/B non-small-cell lung cancer (NSCLC).
Methods:
We queried the National Cancer Database (2010-2020) to identify sociogeographic status through SDH scores, which are based on low income, education levels, rurality, and hospital type (disadvantage: SDH- score 2-4; advantage: SDH + score 0-1). TOO achievement (TOO+) was defined as R0 resection, ≥ 5 lymph nodes harvested, appropriate adjuvant chemotherapy, no 90-day mortality, prolonged hospital stays, and unplanned readmission. Logistic and Cox regression analyses assessed the impact of SDH on TOO + and OS.
Results:
Of 131,134 patients meeting inclusion criteria, 48.8% were TOO + and 30.3% were SDH + . A higher incidence of TOO + was observed in SDH + cohort (P < .001). SDH- patients were 14% less likely to be TOO + and had a significantly worse median OS (8.4 years) compared to SDH + patients (11 years), regardless of TOO status. TOO + correlated with a 2.6-year increase in median OS vs. that of TOO- cohort. The best median OS was observed in SDH+/TOO + patients (12 years) vs. that of SDH-/TOO- patients (7 years). TOO + mitigated the negative impact of SDH- on OS. After adjusting for confounders, SDH- was associated with a 21% higher mortality risk and TOO + independently reduced mortality by 34%.
Conclusions:
SDH significantly influences TOO and OS in the NSCLC patient population. The negative impact of SDH- on OS was mitigated by TOO + . SDH+/TOO + patients had the best OS.
Related Concept Videos
Cancer Survival Analysis
Kaplan-Meier Approach
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...